SPF BREEDING COLONIES AT THE YERKES NPRC: AIDS, HIV VACCINE DVMT
YERKES NPRC 的 SPF 繁殖群:艾滋病、HIV 疫苗 DVMT
基本信息
- 批准号:7961165
- 负责人:
- 金额:$ 28.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-01 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAnimalsAwardBreedingComputer Retrieval of Information on Scientific Projects DatabaseEnsureFeesFundingGoalsGrantHIV vaccineHuman ResourcesIncomeInstitutionMacacaMacaca mulattaMethodsMonkeysNational Center for Research ResourcesPhasePrimatesProceduresReproductionResearchResearch PersonnelResearch SubjectsResourcesSafetyScreening procedureSourceSpecific Pathogen FreesTestingU-Series Cooperative AgreementsUnited States National Institutes of Healthbaseexperiencegerm free conditioninterestjuvenile animalmeetingsprograms
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
DESCRIPTION (provided by applicant): The central objective of this project is to breed rhesus macaques that are specific pathogen free (SPF- as defined by NCRR in RFA RR-G2-005), MHC typed and genetically characterized to provide research subjects to NIH supported investigators for AIDS related research. This objective will be achieved at the YNPRC National Primate Research Center (YNPRC) utilizing an existing colony of 745 SPF macaque monkeys (produced and maintained since 2002 with the support of NCRR Cooperative Agreement U24 RR 018109) and employing skilled and experienced personnel and proven methods and procedures that have been highly successful to date. The existing SPF rhesus macaque colony will be managed to optimize reproduction, both to provide subjects to AIDS investigators, and to increase its total size via breeding. Additionally, during the first two years of this project phase, we will continue recruitment of young animals from YNPRC non-SPF breeding colonies via appropriate testing and separation. The goal is to ensure the availability of SPF subjects to meet the requirements of AIDS investigators, both Emory based and from other institutions regionally and nationally; this is an objective we have achieved very successfully in the past award period (2002 to 2007). The overall YNPRC goal is to transition to an entirely SPF Field Station based rhesus colony by 2013, progressively replacing the non-SPF rhesus macaques in the colony with SPF animals. This goal, although vital to the interests of the Center (and NCRR) in both scientific and safety terms, goes beyond the scope of the present proposal. Thus, we seek here support for a fixed colony of 500 SPF monkeys although we describe a program that includes 745 animals at the outset and that we intend to increase substantially in the proposed award period. The proposed colony of 500 to be supported by this mechanism is level with the effort in the initial award period and, with supplemental animals from our screening program, is sufficient to meet the requirements of our AIDS research portfolio. The SPF animals in excess of the 500 will be supported from program income associated with the base grant (e.g. per diem and use fees) from NCRR to the YNPRC (P51 - RR00165). As the SPF colony grows the conventional colony will be reduced in size, with the goal of achieving a 100% SPF rhesus breeding colony by 2013.
该副本是利用众多研究子项目之一
由NIH/NCRR资助的中心赠款提供的资源。子弹和
调查员(PI)可能已经从其他NIH来源获得了主要资金,
因此可以在其他清晰的条目中代表。列出的机构是
对于中心,这不一定是调查员的机构。
描述(由申请人提供):该项目的核心目的是繁殖特定病原体的猕猴(由NCRR在RFA RR-G2-005中定义的SPF-),MHC键入且遗传学特征,旨在为NIH支持的研究对AIDS相关研究的研究对象提供研究对象。该目标将在YNPRC国家灵长类动物研究中心(YNPRC)中实现,该殖民地现有的殖民地为745 SPF猕猴(自2002年以来生产和维护,并在NCRR合作协议U24 RR 018109的支持下),并雇用了熟练的,经验丰富的人员和经验丰富的人员和经验丰富的方法和迄今已取得了非常成功的方法。现有的SPF恒河猕猴菌落将被设法优化繁殖,既可以为AIDS研究人员提供受试者,又可以通过育种来增加其总尺寸。此外,在此项目阶段的前两年中,我们将通过适当的测试和分离继续招募YNPRC非SPF繁殖菌落的年轻动物。目的是确保SPF受试者的可用性满足基于Emory的AIDS调查人员的要求,以及来自地区和全国其他机构的要求;这是我们在过去的奖项期(2002年至2007年)中成功实现的目标。 YNPRC的总体目标是到2013年过渡到完全基于SPF的恒河类殖民地,并逐渐用SPF动物代替了菌落中的非SPF恒河猕猴。该目标虽然对中心(和NCRR)的利益至关重要,但在科学和安全方面都超出了本提议的范围。因此,我们在这里寻求支持500个SPF猴子的固定菌落,尽管我们描述了一项包括745只动物的程序,并打算在拟议的奖励期间大幅增加。该机制支持的500个殖民地在初始奖励期间的努力水平与我们的筛查计划中的补充动物相满足,足以满足我们的艾滋病研究组合的要求。超过500的SPF动物将得到与基本赠款相关的计划收入(例如,从NCRR到YNPRC)到YNPRC(p51 -rr00165)。随着SPF殖民地的生长,常规菌落的大小将减小,其目标是到2013年达到100%的SPF恒河猴繁殖菌落。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES GIBSON ELSE其他文献
JAMES GIBSON ELSE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES GIBSON ELSE', 18)}}的其他基金
YNPRC NHP CLINICAL MEDICINE RESIDENCY PROGRAM - SUPPLEMENT
YNPRC NHP 临床医学住院医师计划 - 补充
- 批准号:
8357553 - 财政年份:2011
- 资助金额:
$ 28.7万 - 项目类别:
SPF BREEDING COLONIES AT THE YERKES NPRC: AIDS, THERAPEUTIC AGENT DVMT
YERKES NPRC 的 SPF 繁殖群:艾滋病、治疗剂 DVMT
- 批准号:
8359532 - 财政年份:2011
- 资助金额:
$ 28.7万 - 项目类别:
VACCINATION AGAINST INTRAPARTUM HIV-1 CLADE C TRANSMISSION
预防产时 HIV-1 C 类传播的疫苗接种
- 批准号:
8357404 - 财政年份:2011
- 资助金额:
$ 28.7万 - 项目类别:
SPF BREEDING COLONIES AT THE YERKES NPRC: AIDS, ANIMAL MODEL
YERKES NPRC 的 SPF 繁殖群:艾滋病,动物模型
- 批准号:
8359531 - 财政年份:2011
- 资助金额:
$ 28.7万 - 项目类别:
VACCINATION AGAINST INTRAPARTUM HIV-L CLADE C TRANSMISSION SUPPLEMENT
产时接种 HIV-L C 型传播补充剂
- 批准号:
8357549 - 财政年份:2011
- 资助金额:
$ 28.7万 - 项目类别:
SPF BREEDING COLONIES AT THE YERKES NPRC: AIDS, HIV VACCINE DVMT
YERKES NPRC 的 SPF 繁殖群:艾滋病、HIV 疫苗 DVMT
- 批准号:
8359533 - 财政年份:2011
- 资助金额:
$ 28.7万 - 项目类别:
PRIMATE GENETIC ANALYSIS AND PEDIGREE MANAGEMENT
灵长类动物遗传分析和谱系管理
- 批准号:
8357419 - 财政年份:2011
- 资助金额:
$ 28.7万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
以秀丽隐杆线虫为例探究动物在不同时间尺度行为的神经基础
- 批准号:32300829
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
采用新型视觉-电刺激配对范式长期、特异性改变成年期动物视觉系统功能可塑性
- 批准号:32371047
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
脊椎动物胚胎发育单细胞磷酸化蛋白质组高通量高灵敏度分析新技术新方法
- 批准号:22374084
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
新疆旱獭等啮齿动物携带病毒的病原学与病原生态学研究
- 批准号:32300424
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Emory/Georgia TB Research Advancement Center (TRAC)
埃默里/佐治亚州结核病研究促进中心 (TRAC)
- 批准号:
10429403 - 财政年份:2022
- 资助金额:
$ 28.7万 - 项目类别:
Emory/Georgia TB Research Advancement Center (TRAC)
埃默里/佐治亚州结核病研究促进中心 (TRAC)
- 批准号:
10596180 - 财政年份:2022
- 资助金额:
$ 28.7万 - 项目类别:
A Gene Drive Therapy for HIV: single-administration intervention for high-risk groups
HIV基因驱动疗法:针对高危人群的单次给药干预
- 批准号:
10404422 - 财政年份:2021
- 资助金额:
$ 28.7万 - 项目类别:
Evaluation of Self-delivering FANA Antisense Oligonucleotide Lead Compounds for HIV Therapy
自递送 FANA 反义寡核苷酸先导化合物用于 HIV 治疗的评价
- 批准号:
10011742 - 财政年份:2020
- 资助金额:
$ 28.7万 - 项目类别:
Evaluation of Self-delivering FANA Antisense Oligonucleotide Lead Compounds for HIV Therapy
自递送 FANA 反义寡核苷酸先导化合物用于 HIV 治疗的评价
- 批准号:
10232090 - 财政年份:2020
- 资助金额:
$ 28.7万 - 项目类别: